Latest News
Press Releases
Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B Bethesda, MD — March 28...
Solaxa Inc. Announces FDA Clearance of IND Application for SLX-100 Bethesda, MD; January 6, 2024 –...
Solaxa Inc. Collaborates with National Ataxia Foundation Bethesda, MD and Minneapolis, MN;...
Solaxa Inc. Appoints Kerry Clem as Chief Commercial Officer Bethesda, MD; August 19, 2024 –...
U.S. Food and Drug Administration Grants Orphan Drug Designation to Solaxa Inc. ...
Solaxa Inc. Appoints Amy Chappel, MD, FAAN as Chief Medical Officer Bethesda, MD; January 1...
Solaxa Inc. Begins Operations as a Public Benefit Corporation Bethesda, MD; February 24, 2022 –...
News
TEDCO Announces SSBCI Investment in Solaxa Inc. Maryland-based biopharmaceutical company receives funding from TEDCO’s Venture Funds COLUMBIA, Md., (July 23...
The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today announced the winners...
Rockville, Maryland – September 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading regional innovation intermediary, is thrilled to announce...
- 1
- 2